BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1323646)

  • 41. [The expression of plasminogen activator inhibitor-1 (PAI-1) gene in human astrocytomas].
    Bu X; Zhang X; Cao W
    Zhonghua Bing Li Xue Za Zhi; 1998 Dec; 27(6):433-5. PubMed ID: 11244954
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical localization of basic fibroblast growth factor in astrocytomas.
    Zagzag D; Miller DC; Sato Y; Rifkin DB; Burstein DE
    Cancer Res; 1990 Nov; 50(22):7393-8. PubMed ID: 2171762
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells.
    Zscharnack K; Kessler R; Bleichert F; Warnke JP; Eschrich K
    Neuropathol Appl Neurobiol; 2009 Dec; 35(6):566-78. PubMed ID: 19490427
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of the vitamin D receptor, 25-hydroxylases, 1alpha-hydroxylase and 24-hydroxylase in the human kidney and renal clear cell cancer.
    Blomberg Jensen M; Andersen CB; Nielsen JE; Bagi P; Jørgensen A; Juul A; Leffers H
    J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):376-82. PubMed ID: 20362668
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Role of adrenomedullin in glioblastomas growth].
    Boudouresque F; Berthois Y; Martin PM; Figarella-Branger D; Chinot O; Ouafik L
    Bull Cancer; 2005 Apr; 92(4):317-26. PubMed ID: 15888388
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mdr1 mRNA expression differs between grade III astrocytomas and glioblastomas.
    Kirches E; Oda Y; Von Bossanyi P; Diete S; Schneider T; Warich-Kirches M; Dietzmann K
    Clin Neuropathol; 1997; 16(1):34-6. PubMed ID: 9020393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation.
    Lehnhardt FG; Bock C; Röhn G; Ernestus RI; Hoehn M
    NMR Biomed; 2005 Oct; 18(6):371-82. PubMed ID: 15959923
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of gemistocytes in astrocytoma progression.
    Watanabe K; Tachibana O; Yonekawa Y; Kleihues P; Ohgaki H
    Lab Invest; 1997 Feb; 76(2):277-84. PubMed ID: 9042164
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Upregulation of frizzled 9 in astrocytomas.
    Zhang Z; Schittenhelm J; Guo K; Bühring HJ; Trautmann K; Meyermann R; Schluesener HJ
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):615-24. PubMed ID: 17083476
    [TBL] [Abstract][Full Text] [Related]  

  • 50. ADAM12 is selectively overexpressed in human glioblastomas and is associated with glioblastoma cell proliferation and shedding of heparin-binding epidermal growth factor.
    Kodama T; Ikeda E; Okada A; Ohtsuka T; Shimoda M; Shiomi T; Yoshida K; Nakada M; Ohuchi E; Okada Y
    Am J Pathol; 2004 Nov; 165(5):1743-53. PubMed ID: 15509542
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genome-wide oligonucleotide microarray analysis of gene-expression profiles of Taiwanese patients with anaplastic astrocytoma and glioblastoma multiforme.
    Chang CL
    J Biomol Screen; 2008 Oct; 13(9):912-21. PubMed ID: 18812569
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system.
    Van Meir E; Ceska M; Effenberger F; Walz A; Grouzmann E; Desbaillets I; Frei K; Fontana A; de Tribolet N
    Cancer Res; 1992 Aug; 52(16):4297-305. PubMed ID: 1643627
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme].
    Huettner C; Paulus W; Roggendorf W
    Verh Dtsch Ges Pathol; 1994; 78():418-22. PubMed ID: 7534012
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of estrogen and progesterone receptors in astrocytomas: a literature review.
    Tavares CB; Gomes-Braga Fd; Costa-Silva DR; Escórcio-Dourado CS; Borges US; Conde-Junior AM; Barros-Oliveira Mda C; Sousa EB; Barros Lda R; Martins LM; Facina G; da-Silva BB
    Clinics (Sao Paulo); 2016 Aug; 71(8):481-6. PubMed ID: 27626480
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Complement gene expression in neuroblastoma and astrocytoma cell lines of human origin.
    Walker DG; McGeer PL
    Neurosci Lett; 1993 Jul; 157(1):99-102. PubMed ID: 8233040
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biosynthesized products of cultured neuroglial cells: I. Selective release of proteins by cells from human astrocytomas.
    McKeever PE; Quindlen E; Banks MA; Williams U; Kornblith PL; Laverson S; Greenwood MA; Smith B
    Neurology; 1981 Nov; 31(11):1445-52. PubMed ID: 7031502
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular biology of the vitamin D hormone.
    Haussler MR; Mangelsdorf DJ; Komm BS; Terpening CM; Yamaoka K; Allegretto EA; Baker AR; Shine J; McDonnell DP; Hughes M
    Recent Prog Horm Res; 1988; 44():263-305. PubMed ID: 2851156
    [No Abstract]   [Full Text] [Related]  

  • 59. Daily Lifestyle Modifications to Improve Quality of Life and Survival in Glioblastoma: A Review.
    Travers S; Litofsky NS
    Brain Sci; 2021 Apr; 11(5):. PubMed ID: 33922443
    [TBL] [Abstract][Full Text] [Related]  

  • 60. From epidemiology and neurometabolism to treatment: Vitamin D in pathogenesis of glioblastoma Multiforme (GBM) and a proposal for Vitamin D + all-trans retinoic acid + Temozolomide combination in treatment of GBM.
    Elmaci I; Ozpinar A; Ozpinar A; Perez JL; Altinoz MA
    Metab Brain Dis; 2019 Jun; 34(3):687-704. PubMed ID: 30937698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.